Stuart Guterman currently is an independent consultant. From July 2015 through December 2016, he was a Senior Scholar in Residence at AcademyHealth in Washington, DC. From 2005 through 2015, he was a Vice President at the Commonwealth Fund, a private foundation that aims to promote improved access, higher quality, and greater efficiency, particularly for society’s most vulnerable. There, he led several programs, including special initiatives on Advancing Medicare and Controlling Health Care Costs, and the Program on Payment and System Reform, and served as Executive Director of the Commonwealth Fund Commission on a High Performing Health System.
From 2002 to 2005, Mr. Guterman was Director of the Office of Research, Development, and Information at the Centers for Medicare and Medicaid Services, the U.S. government agency responsible for setting policy for the country’s two largest public health programs. Prior to that, he was a Senior Analyst at the Congressional Budget Office, a Principal Research Associate at the Urban Institute, Deputy Director of the Medicare Payment Advisory Commission, and Chief of Institutional Studies at the Health Care Financing Administration.
He holds an A.B. in Economics from Rutgers College and an M.A. in Economics from Brown University, and did further work toward the Ph.D. in Economics at the State University of New York at Stony Brook.
Recent Posts by Stuart Guterman
All too often, criticisms of CBO’s methods are motivated by a misunderstanding of what CBO can and cannot be expected to do. As we engage in a new round of health policy debate, it is vital to examine CBO's role in the legislative process.
Moving from a system that rewards volume over value is a complicated and messy process. No method is ever implemented in isolation---either one at a time or in a vacuum---and many payment methods do not yet have a sufficient track record to help us prioritize among them.
Medicare has been successful in assuring the health and economic security of the nation’s elderly and disabled. As it enters its second 50 years, the program faces considerable challenges and better strategies are needed to serve the growing number of beneficiaries.
Much of the debate over the health spending slowdown has been centered on three questions: What has caused this slowdown? Is it really a change? Will it continue? If these are not the wrong questions, they at least should be asked in a more productive context than often has been the case.
Editor's note: See Robert Berenson's post on consolidation and market power in health care, also published today, and watch for more on these subjects in Health Affairs Blog. Health Affairs last week posted a set of papers that represent several perspectives on Provider Consolidation in...